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ABSTRACT 
Background: Mouse models of heart disease are extensively employed. The 
echocardiographic characterization of contractile function is usually focused on 
systolic function with fewer studies assessing diastolic function. Furthermore, the 
applicability of diverse echocardiographic parameters of diastolic function that are 
commonly used in humans has not been extensively evaluated in different 
pathophysiological models in mice. Methods and Results: We used high resolution 
echocardiography to evaluate parameters of diastolic function in mouse models of 
chronic pressure overload (aortic constriction), volume overload (aorto-caval shunt), 
heart failure with preserved ejection fraction (HFpEF; DOCA-salt hypertension), and 
acute sarcoplasmic reticulum dysfunction induced by thapsigargin - all known to 
exhibit diastolic dysfunction. Left atrial area increased in all three chronic models 
while mitral E/A was difficult to quantify at high heart rates. Isovolumic relaxation time 
(IVRT) and Doppler E/E’ increased significantly and the peak longitudinal strain rate 
during early filling (peak reverse longitudinal strain rate) decreased significantly after 
aortic constriction, with the changes being proportional to the magnitude of 
hypertrophy. In the HFpEF model, reverse longitudinal strain rate decreased 
significantly but changes in IVRT and E/E’ were non-significant, consistent with less 
severe dysfunction. With volume overload, there was a significant increase in reverse 
longitudinal strain rate and decrease in IVRT, indicating a restrictive physiology. 
Acute thapsigargin treatment caused significant prolongation of IVRT and decrease 
in reverse longitudinal strain rate. Conclusion: These results indicate that the 
combined measurement of left atrial area plus reverse longitudinal strain rate and/or 
IVRT provide an excellent overall assessment of diastolic function in the diseased 
mouse heart, allowing distinction between different types of pathophysiology. 
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1. Introduction 
Systolic heart failure is invariably accompanied by left ventricular (LV) diastolic 
dysfunction but the latter often also occurs in the absence of (or precedes) significant 
systolic dysfunction in many human diseases. Conditions that may be associated 
with isolated diastolic dysfunction include hypertensive cardiac hypertrophy, diabetes 
mellitus, obesity, metabolic syndrome and aging [1,2]. Many patients with overt heart 
failure have predominantly diastolic dysfunction with relatively well-preserved systolic 
function - termed "heart failure with preserved ejection fraction (HFpEF)".2 The 
prevalence of HFpEF has been suggested to be up to 50% of all heart failure cases 
and the condition imposes significant morbidity and mortality.2, 3  
Echocardiography is immensely valuable in the non-invasive evaluation of human 
LV diastolic function. The term diastolic function encompasses active myocardial 
relaxation, which significantly influences early ventricular filling, as well as passive 
end-diastolic ventricular stiffness, which impacts on late ventricular filling. Different 
echocardiographic parameters assess different aspects of diastolic function, its 
consequences and/or determinants. An impairment of relaxation is readily detected 
by a prolongation of the isovolumic relaxation time (IVRT, assessed from aortic and 
mitral Doppler recordings) or the mitral Doppler inflow E-wave deceleration time 
(DT).4 The ventricular filling pattern on transmitral Doppler, often reported as the ratio 
between early and late filling (E/A ratio), is a deceptively simple measure that needs 
to be carefully interpreted because it is influenced not only by myocardial relaxation 
and ventricular stiffness but also by the left atrial pressure.4, 5 Adding to the 
complexity, the left atrial pressure is itself affected by left ventricular properties (it 
tends to rise as the ventricle becomes stiffer). The E/A ratio decreases when 
relaxation is significantly impaired but rises again with the progression of diastolic 
dysfunction when left atrial pressure increases (termed "pseudo-normalization”). A 
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further increase in LV passive stiffness may lead to a predominantly early filling 
pattern with abrupt termination of filling - a so-called “restrictive” pattern.4 In this case, 
there is a marked decrease in IVRT and DT along with an increase in E/A ratio and 
an accurate interpretation of the physiology requires the measurement of multiple 
parameters. Given the importance of left atrial pressure for diastolic function, 
parameters that provide information about left atrial properties are very useful. The 
E/E’ ratio (mitral inflow E wave/tissue Doppler mitral annulus velocity) correlates with 
left atrial pressure while the left atrial volume provides a useful indication of 
chronically elevated left atrial pressure.5, 6  
Genetic, surgical and pharmacological mouse models of cardiovascular disease 
are widely used in experimental research. The mouse is often the experimental 
model of choice due to the availability of homogenous strains, the ease of genome 
manipulation and breeding, and the extensive range of gene-modified models 
available to researchers. Additionally, there are multiple established surgical and 
pharmacological procedures to model human cardiac conditions in mice. The non-
invasive assessment of cardiac function in such models is, however, largely focused 
on systolic function using standard views whereas diastolic properties tend to be 
quantified in a rudimentary manner. The main reason for this is the technical 
challenge in assessing diastolic function at physiologically high heart rates (400-600 
bpm) in a very small organ. 
The aim of this study was to assess which of the several echocardiographic 
parameters of diastolic function that are commonly used in humans can be reliably 
applied in mice and whether their applicability differs according to the specific 
pathophysiological mouse model of cardiovascular stress. We then wanted to design 
a simple, technically straightforward algorithm to guide detection and distinction 
between different patterns of diastolic dysfunction in mice. 
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2. Material and methods 
2.1. Animals 
Studies were conducted in C57Bl/6 mice, in accordance with the UK Home Office 
Guidance on the Operation of the Animals (Scientific Procedures) Act, 1986 and with 
institutional ethics approval. 
 
2.2. Experimental models 
Surgical procedures were either performed under 1.5% isoflurane (TAC, Shunt) 
or injectable anesthesia with ketamine (75 mg/kg) plus medetomidine hydrochloride 
(1 mg/kg) (AAB, DOCA-salt hypertension). We used 2 models of chronic pressure 
overload, namely suprarenal abdominal aortic banding (AAB) and transverse aortic 
constriction (TAC). AAB was performed in mice weighing 16-18g using a 28-gauge 
band.7 Sham constriction involved identical surgery apart from band placement. 
Animals were studied six weeks post-surgery. Minimally invasive TAC surgery was 
performed using a 27-gauge needle to constrict the aorta between the 
brachiocephalic and left common carotid arteries.8 Sham operated mice underwent 
the same procedure apart from constriction. Mice were studied two weeks after TAC. 
Chronic volume overload was induced by producing an aortocaval fistula 
(Shunt).9 Briefly, the aorta and inferior vena cava were dissected free, the aorta was 
clamped just above the renal arteries, and was then punctured with a 23-gauge 
needle passing through to the inferior vena cava in an infra-renal position. The lateral 
puncture site of the aorta was sealed with cyanoacrylate glue. Sham animals 
underwent the same procedure except for vessel puncture. Animals were studied one 
week post-surgery. 
The deoxycorticosterone acetate (DOCA)-salt model of hypertension, which 
causes primarily diastolic rather than systolic impairment,10 was studied. A unilateral 
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nephrectomy was performed under i.p. ketamine and medetomide anesthesia, 
followed by subcutaneous implantation of a DOCA pellet (0.7 mg/day). Animals 
additionally received a 1% NaCl drinking water solution. The Sham group underwent 
surgery without nephrectomy, DOCA or salt. Mice were studied by echocardiography 
21 days post-surgery, followed by cardiac catheterization for LV pressure-volume 
analysis. 
As an acute model of diastolic dysfunction, mice were treated with a single dose 
of thapsigargin (0.75 mg/kg i.p.; Sigma-Aldrich, UK), an inhibitor of the sarcoplasmic 
reticulum Ca2+-ATPase.11 Echocardiography was performed prior to and five hours 
following thapsigargin. 
 
2.3. Heart weight measurement 
After sacrifice of animals, the heart was excised and dissected into its four 
chambers. Organs were weighed and the heart or left ventricular weight was 
normalized by the total body weight (BW). 
 
2.4. Echocardiography 
Mice were anesthetised with 1.5% isoflurane and imaged in the supine position 
using a Vevo 2100 Imaging System with a 40-MHz linear probe (Visualsonics, 
Canada). Core temperature was maintained at 37oC. Heart rates were kept 
consistent between experimental groups (400-500 bpm). ECG monitoring was 
obtained using limb electrodes. A standard 2D echocardiographic study was initially 
performed in the parasternal long-axis view for assessment of LV dimensions and 
systolic function. Image depth, width and gain settings were used to optimise image 
quality. Frame rates were >150 Hz with a mean of 201 Hz (±24).  
Diastolic parameters were evaluated as follows: 
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Doppler flow profiles were acquired using pulsed wave Doppler in the apical 4-
chamber view. The sample volume was placed close to the tip of the mitral leaflets in 
the mitral orifice parallel to the blood flow in order to record maximal transmitral flow 
velocities. To assess IVRT, a simultaneous mitral inflow and aortic outflow profile was 
recorded, allowing measurement of the time interval between aortic valve closure and 
mitral valve opening.  
Tissue Doppler imaging in the apical 4-chamber view was performed by placing 
the pulsed wave Doppler at the septal corner of the mitral annulus. E´ was 
determined as peak mitral annular velocity during early filling. 
Left atrial area was quantified in the apical 4-chamber view by tracing the border 
of the left atrium. Measurement was performed in end-systole before opening of the 
mitral valve. 
Speckle tracking was performed as described previously.12 Briefly, a number of 
tracking points were placed on the endocardial and epicardial border in the 
parasternal long axis view using the Vevo2100 Imaging Software 1.5.0. Subsequent 
frame by frame tracking through the cardiac cycle allowed automatic calculation of 
strain and strain rates. The software divides the LV into six segments and calculates 
longitudinal and radial strain and strain rates for each segment as well as overall 
mean values. The data presented in this study are the mean global longitudinal strain 
rate values. To quantify the peak longitudinal strain rate during early LV filling, the 
“reverse peak” option in the Vevo2100 1.5.0 Image Software was used 
(Supplementary Fig. 1A). We term this parameter the peak reverse longitudinal strain 
rate (rLSR). 
All views were digitally stored in cine loops consisting of 300 frames. Subsequent 
analyses were performed off-line by an experienced sonographer who was blinded to 
the type of mouse model. LV volumes and ejection fraction (EF) were obtained using 
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the standard 2D quantification software. Inter-observer and intra-observer variability 
for indices of diastolic function were evaluated from 10 randomly selected 
echocardiographic studies, analyzed in a blinded manner on two separate occasions 
by the same observer (intra-observer variability) and by two independent observers 
(inter-observer variability). 
 
2.5. Cardiac catheterization 
LV pressure-volume analysis was performed using a 1.2F microconductance 
catheter system (Scisense Inc.) inserted via the right carotid artery and positioned at 
the LV apex.13 Data were collected using the ADVantage™ system (Scisence Inc.) 
coupled to a Powerlab/8SP with Chart Software (ADinstruments). Analyses were 
performed using Labscribe (IWork Systems Inc.) software.  
 
2.6. Statistics 
Data are presented as mean ± SEM. Two group comparisons were performed by 
unpaired Student’s t-test or a paired Student’s t-test, as appropriate. Correlations 
were assessed using linear regression and coefficients of determination (r2). p<0.05 
was considered significant. 
 
3. RESULTS 
3.1. Echocardiographic features during chronic pressure overload 
Six weeks after AAB, there was significant LV hypertrophy (LVH) as assessed by 
the LV/body weight ratio (Fig. 1A). Heart rates were similar in the banded and sham 
groups (Fig. 1B). There was significant systolic dysfunction in the AAB group as 
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evidenced by reductions in EF and the mean global longitudinal strain rate (Fig. 1C-
D). 
Turning to diastolic parameters, IVRT was significantly prolonged in AAB versus 
Sham, indicating impaired relaxation (Fig. 2A). The E/E’ ratio was significantly higher 
in AAB compared to Sham (Fig. 2B). The peak reverse longitudinal strain rate, 
quantified as an index of the peak early LV filling rate, was significantly decreased in 
AAB compared to Sham (Fig. 2C). Left atrial area or volume is a sensitive marker of 
chronic diastolic dysfunction and elevated left atrial pressure in humans.14 In mice, 
left atrial area was found to be significantly higher in AAB versus Sham (Fig. 2D). 
Representative examples of the IVRT traces, apical 4-chamber images and tissue 
Doppler traces are shown in Fig. 3A-B and Supplementary Fig. 2. The E/A ratio and 
the E-wave deceleration time (DT) could not be evaluated consistently at high heart 
rates, which were associated in over 50% of cases with fusion of the E and A waves. 
A similar pattern of changes was observed in the TAC model of chronic pressure 
overload (Supplementary Fig. 3). There was evidence of systolic dysfunction 
(reduced EF) and LVH (increased LV/body weight ratio), as expected. Diastolic 
dysfunction was evident from a prolonged IVRT, elevated E/E’ ratio, decreased 
reverse longitudinal strain rate, and an increased left atrial area.  
The inter- and intra-observer variability for diastolic parameters are shown in 
Table 1. 
 
3.2. Inter-relationship of diastolic parameters during cardiac hypertrophy 
The relative change in IVRT correlated significantly and positively with that in the 
E/E´ ratio in the combined group of TAC and AAB pressure overload models (Fig. 
4A). The correlation between relative IVRT and reverse longitudinal strain rate 
changes was not significant (p=0.06) (Fig. 4B). There was no correlation between the 
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changes in reverse longitudinal strain rate and E/E´, and changes in left atrial area 
also did not correlate with any of the other three parameters (Supplementary Fig. 4). 
We assessed the relationship between the magnitude of change in these parameters 
and the extent of cardiac hypertrophy. This analysis showed that the percentage 
changes in reverse longitudinal strain rate, IVRT and E/E’ were each significantly and 
positively correlated with the extent of hypertrophy (Fig. 4C-E). However, there was 
no correlation between the relative increase in left atrial area and extent of 
hypertrophy (Fig. 4F). 
 
3.3. Diastolic dysfunction during chronic volume overload 
One week after generation of an aortocaval fistula, the Shunt group showed 
evidence of eccentric LVH as assessed by increases in echocardiographic left 
ventricular end-diastolic dimensions (4.7±0.09 vs 4.0±0.10 mm, p<0.01) and LV/body 
weight ratio (Fig. 1E). Heart rates were similar between groups (Fig. 1F). The Shunt 
group were in a hypercontractile stage with a significantly higher EF and mean global 
longitudinal strain rate than Sham (Fig. 1G-H). 
Left atrial area was significantly increased in Shunt compared to Sham (Fig. 2H; 
Fig. 3B). In marked contrast to chronic pressure overload, IVRT was significantly 
reduced in Shunt (Fig. 2E; Fig. 3A) and the peak reverse longitudinal strain rate was 
significantly increased compared to Sham (Fig. 2G). There was no significant 
difference in the E/E’ ratio between Shunt and Sham (Fig. 2F). 
 
3.4. Assessment of a mouse model of HFpEF 
The DOCA-salt model has been proposed as a mouse model of HFpEF.10 Unlike 
AAB, TAC and shunt, this model has not been extensively studied in the mouse and 
we therefore first performed invasive LV pressure-volume analysis. This confirmed a 
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preserved EF with evidence of impaired relaxation (a reduced dP/dtmin and a 
prolonged isovolumic relaxation time constant, Tau) and increased LV end-diastolic 
pressure (Fig. 5). There was moderate LVH, as assessed by the HW/body weight 
ratio (5.08±0.05 vs 4.87±0.07 mg/g, p=0.04), and evidence of mild systolic 
dysfunction as assessed by dP/dtmax normalized for end-diastolic volume (EDV).  
Assessment by echocardiography also demonstrated a preserved EF (Fig. 6). 
There was a significant decrease in the reverse longitudinal strain rate with a 
borderline increase in IVRT and no change in E/E´ in the DOCA-salt group compared 
to control (Fig. 6C-E). Left atrial area showed a significant increase in the DOCA-salt 
group (Fig. 6F).  
 
3.5. Acute response to the sarcoplasmic reticulum Ca2+-ATPase inhibitor 
thapsigargin  
Treatment with thapsigargin did not affect heart rates, but caused a significant 
decrease in systolic function (Fig. 7A-B). It resulted in a significant increase in IVRT 
and a significant decrease in the reverse longitudinal strain rate (Fig. 7C-D), 
consistent with impairment of relaxation and early LV filling. However, there were no 
changes in the left atrial area or the E/E’ ratio (Fig. 7E-F).  
  
4. DISCUSSION 
The echocardiographic criteria for the assessment of LV diastolic function in 
humans are well established.5, 15 A central parameter for the diagnosis of diastolic 
dysfunction that is recommended by the European Society of Cardiology is the E/E’ 
ratio, which requires tissue Doppler and mitral pulse wave Doppler measurements.16 
The E/E’ ratio correlates with LV filling pressure, which increases as diastolic 
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dysfunction progresses, and an E/E’ ratio>15 is considered abnormal in humans.6 If 
the E/E’ ratio is between 8 and 15 and therefore potentially suggestive of diastolic 
dysfunction, it is recommended to also assess the mitral E/A ratio, E-wave 
deceleration time and the left atrial volume index. IVRT and diastolic LV strain 
analysis are not part of the European Society of Cardiology algorithm,16 but have 
been used in many clinical studies. No analogous algorithm is available for the 
assessment of LV diastolic function in the mouse heart, and the few studies that do 
assess diastolic function do not appear to have a clear rationale for the choice of 
measured parameter. Furthermore, the parameters that are used in human studies 
cannot necessarily be extrapolated to mouse studies, given the substantial 
differences in heart rate and organ size between species. The current study therefore 
evaluated the applicability of several different parameters to assess LV diastolic 
function in mice. In addition, we investigated these parameters in diverse 
experimental models since the pattern of diastolic dysfunction may vary according 
the type of hemodynamic or other stress and different parameters may be useful in 
different settings. Accordingly, we included models of chronic pressure overload with 
combined systolic and diastolic dysfunction (AAB and TAC), a model of chronic 
volume overload with hypercontractile function (Shunt), a model of HFpEF (DOCA-
salt), and a model of acute contractile dysfunction (thapsigargin). Based on this wide 
range of models, we aimed to develop a simple algorithm to guide the 
characterization of diastolic dysfunction that could be applied to diverse mouse 
models. To the best of our knowledge, this is the first study to systematically 
undertake such an analysis.  
Although IVRT is not routinely quantified in human studies, it is a well-established 
and sensitive marker of impaired LV relaxation4 and has been employed in some 
previous mouse studies.17, 18 We found that IVRT was technically quite 
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straightforward to quantify by echocardiography in the mouse heart at physiological 
heart rates. IVRT increased significantly in both chronic pressure overload models 
(AAB and TAC) as well as during acute sarcoplasmic reticulum dysfunction induced 
by thapsigargin. This is in line with the knowledge that pressure overload-induced 
LVH is accompanied by impaired relaxation and that sarcoplasmic reticulum function 
is crucial for relaxation. Since a significant impairment of LV isovolumic relaxation will 
slow down early ventricular filling, we reasoned that this would be reflected in the 
peak myocardial longitudinal strain rate during early filling (the reverse longitudinal 
strain rate). This parameter has only rarely been used in human or animal studies19 
but it is potentially attractive because it is technically very straightforward to estimate 
with systems that use speckle tracking to quantify myocardial strain. We found that 
the reverse longitudinal strain rate decreased in both surgical pressure overload 
models as well as after thapsigargin treatment. Changes in reverse longitudinal strain 
rate paralleled those in IVRT during pressure overload, suggesting that they may 
provide similar information. Furthermore, the magnitude of change in both 
parameters was significantly correlated to the extent of hypertrophy. Analyses in the 
HFpEF model, where an impairment in LV relaxation was confirmed by invasive 
measurement of LV dP/dtmin and Tau, showed that the reverse longitudinal strain rate 
was significantly decreased compared to Sham but that there was only a borderline 
increase in IVRT. This suggests that while IVRT and reverse longitudinal strain rate 
respond to similar pathophysiology, the latter may be a more sensitive marker.  
The volume overload (Shunt) model causes a markedly greater increase in LV 
end-diastolic volume and end-diastolic wall stress than pressure overload, resulting in 
a “restrictive” LV filling pattern with an increased early filling rate and an abrupt 
termination of filling.9, 20 This was readily detected by a significant decrease in IVRT 
and a significant increase in the reverse longitudinal strain rate in this model. It is 
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notable that the changes in IVRT and reverse longitudinal strain rate were in opposite 
directions in volume overload versus pressure overload, therefore highlighting that 
these echocardiographic parameters easily enable a distinction to be made between 
the different types of diastolic physiology; i.e. impaired relaxation in pressure 
overload versus restrictive filling in volume overload LVH. 
The E/E’ ratio is one of the parameters that is most widely used to assess 
diastolic dysfunction in humans,16 and has also been used in many murine studies.21-
23 The E/E’ increased significantly in both our chronic pressure overload models as 
compared to Sham. However, we found no increase in E/E’ in the DOCA-salt model 
despite invasive evidence of an increased LV filling pressure (LVEDP). Likewise, no 
increase in E/E’ was observed in the Shunt model, which is known to have a greatly 
elevated filling pressure.9 The same was true after acute treatment with thapsigargin. 
These results suggest that the value of measurement of the E/E’ ratio is highly 
model-dependent, a finding probably related to the differences in pathophysiology 
among models. 
Left atrial area or volume is a very useful parameter to assess diastolic function in 
humans, reflecting a chronic increase in LV filling pressures.14, 16, 24 However, it is 
rarely measured in murine studies.25 We found that measurement of left atrial area in 
the mouse heart was relatively straightforward in the apical 4-chamber view. 
Furthermore, left atrial area was significantly increased in all four chronic models, i.e. 
AAB, TAC, Shunt and DOCA-salt models, in line with increased filling pressures in all 
models. It was however unchanged in the acute thapsigargin model. Therefore, left 
atrial area appears to be a very good marker of chronically elevated filling pressures 
across different murine cardiac models, in contrast to the E/E’ ratio. This is consistent 
with a human study that demonstrated a higher sensitivity for left atrial dimensions as 
compared to E´-related parameters in detecting LV diastolic dysfunction in patients 
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with a normal EF.26 It should be noted, however, that the relative increase in left atrial 
area was not significantly correlated with the extent of hypertrophy; this may reflect a 
high sensitivity of left atrial dilatation to elevated filling pressure but a non-linear 
response.  
The E/A ratio and the E-wave deceleration time (DT) are commonly used in 
human echocardiography16 and have also been used in many mouse studies.21, 27 
We found that it was very challenging or impossible to consistently measure these 
values in mice at heart rates >450 bpm due to fusion of the E- and A-waves, as 
previously noted by others. A consistent measurement of E/A ratio in the mouse 
heart is probably only feasible if heart rate is artificially reduced, for example with 
deeper anesthesia, but this is undesirable due to the likelihood of associated cardiac 
depression.28 Therefore, the routine assessment of these parameters is unlikely to be 
useful in mouse echocardiography.  
The pathophysiology of LV diastolic dysfunction is of increasing interest given the 
focus on identifying effective therapies for HFpEF and the increasing prevalence of 
conditions such as hypertensive LVH and metabolic syndrome that predispose to 
HFpEF. However, the application of well characterized methods to carefully study LV 
diastolic dysfunction by echocardiography in experimental mouse models has lagged 
behind. The results of the present study provide a framework for the systematic 
analysis of LV diastolic function in the mouse heart (Fig. 8). We propose that the left 
atrial area (a marker of LV filling pressure) is an optimal parameter for the detection 
of chronic LV diastolic dysfunction. The subsequent quantification of either reverse 
longitudinal strain rate or IVRT enables distinction between “usual” diastolic 
dysfunction and a restrictive physiology. The E/E’ ratio appears to be very useful in 
pressure overload models but less so in volume overload or HFpEF models in the 
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mouse. Additional echocardiographic indices of diastolic function are probably 
unnecessary in the majority of cases.  
 
Glossary 
AAB, abdominal aortic banding 
DOCA, deoxycorticosterone acetate 
DT, deceleration time  
EDV, end-diastolic volume  
EF, ejection fraction 
IVRT, Isovolumic relaxation time 
HFpEF, heart failure with preserved ejection fraction 
TAC, transverse aortic constriction 
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FIGURE LEGENDS 
 
Figure 1. LV hypertrophy and echocardiographic assessment of LV function in 
murine models of pressure and volume overload. Left ventricular weight versus 
body weight ratio (LV/BW), heart rate, ejection fraction and longitudinal strain rate 
were compared in mice after AAB (A-D) and Shunt (E-H) or the respective control 
procedures (ShamA and ShamS). n=6-7/group; ** p<0.01; n.s., not significant. 
 
Figure 2. LV diastolic function in mouse models of pressure and volume 
overload. Isovolumic relaxation time (IVRT), E/E´, reverse longitudinal strain rate 
(rLSR) and left atrial (LA) area were measured after AAB (A-D) or Shunt (E-H). 
ShamA and ShamS denote the respective control groups. n=6-7/group; ** p<0.01; n.s., 
not significant 
 
Figure 3. Representative Doppler flow profiles for measurement of IVRT and 
apical 4-chamber views for measurement of left atrial area. A. IVRT 
measurement (in blue) from the aortic outflow and mitral inflow profiles in the AAB 
and Shunt groups. B. Left atrial area measurement (dotted red lines) in the AAB and 
Shunt groups compared to their respective controls (ShamA and ShamS). 
 
Figure 4. Correlation of diastolic parameters and cardiac hypertrophy in 
models of pressure overload. The % change in IVRT relative to the control Sham 
group was computed and plotted against the % change in E/E’ (A) or reverse 
longitudinal strain rate (rLSR) (B). The AAB (black symbols) and TAC (red symbols) 
groups were combined. C-F. Correlation of changes in diastolic function parameters 
(rLSR, IVRT, E/E´ and left atrial (LA) area) with the relative increases in heart 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
23 
 
weight/body weight ratio. n=11-13/group. The coefficients of determination (r2) from 
linear regression analysis and p-values are shown on the graphs.  
 
Figure 5. Invasive LV pressure-volume analysis of systolic and diastolic 
function in a mouse DOCA-salt model of HFpEF. A. Heart rate; B. Ejection 
fraction; C. LV dP/dtmin; D. Isovolumic relaxation time constant, Tau (Mirsky); E. LV 
end-diastolic pressure (EDP); F. LV dP/dtmax/ normalized by end-diastolic volume 
(EDV). n=3-7/group; * p<0.05.  
 
Figure 6. Non-invasive echocardiographic assessment of diastolic function in a 
mouse DOCA-salt model of HFpEF. A. Heart rate; B. Ejection fraction; C. Reverse 
longitudinal strain rate (rLSR); D. Isovolumic relaxation time (IVRT); E. E/E´ ratio; F. 
Left atrial (LA) area. n=6-8/group; * p<0.05, ** p<0.01. 
 
Figure 7. Effect of acute thapsigargin treatment on diastolic function. A-F. 
Effect of thapsigargin (Thapsig.; 0.75 mg/kg intraperitoneally) on heart rate, ejection 
fraction (EF), IVRT, reverse longitudinal strain rate (rLSR), left atrial (LA) area and 
E/E’ respectively. n=5-6/group; ** p<0.01. 
 
Figure 8. Algorithm for assessment of chronic LV diastolic dysfunction in mice. 
If the left atrial (LA) area is unchanged compared to control mice, chronic diastolic 
dysfunction is unlikely. If the LA area is increased, subsequent assessment of the 
isovolumic relaxation time (IVRT) and reverse longitudinal strain rate (rLSR) can be 
used to distinguish between “usual” and “restrictive” diastolic dysfunction. 
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Table 1. Intra- and interobserver variability of diastolic parameters. The 
coefficient of variation is shown for measurements of the isovolumic relaxation time 
(IVRT), E/E´, reverse longitudinal strain rate (rLSR) and left atrial (LA) area. 
 
Parameter Intra-observer coefficient 
of variation 
Inter-observer coefficient 
of variation 
IVRT 1.51% 5.05% 
E/E´ 1.86% 7.88% 
rLSR 4.77% 4.71% 
LA area 2.31% 3.19% 
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Fig. 2 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
26 
 
 
Fig. 3 
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Fig. 5 
 
Fig. 6 
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Fig. 7 
 
Fig. 8 
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HIGHLIGHTS 
 
 
 Several echocardiographic indices of diastolic function are applicable to 
mouse models 
 Isovolumic relaxation time (IVRT) and peak strain during filling are easily 
quantified 
 Left atrial area increases with pressure and volume overload as well as 
HFpEF     
 Changes in IVRT and strain during filling distinguish restrictive physiology 
 Combined left atrial area and diastolic strain provide an ideal diagnostic 
framework 
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